Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
Authors:
- 1 October 2007
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 134 (2) , 196-201
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Serum anti-Mullerian hormone throughout the human menstrual cycleHuman Reproduction, 2006
- Serum anti-müllerian hormone levels in women with secondary amenorrheaFertility and Sterility, 2006
- Combined oral contraceptives in the treatment of polycystic ovary syndromeHuman Reproduction Update, 2005
- Anti-Müllerian hormone concentrations in maternal serum during pregnancyHuman Reproduction, 2005
- Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristicsFertility and Sterility, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- Acog Practice Bulletin. No 41, December 2002. Polycistic Ovary SyndromeInternational Journal of Gynecology & Obstetrics, 2003
- Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulationHuman Reproduction, 2003
- Anti-Müllerian hormone in early human developmentEarly Human Development, 1993
- Medical implications of ultrasonically detected polycystic ovariesJournal of Clinical Ultrasound, 1981